[1] |
SCHEITZ JF, NOLTE CH, DOEHNER W, et al. Stroke-heart syndrome: clinical presentation and underlying mechanisms[J]. Lancet Neurol, 2018, 17(12): 1109-1120. DOI: 10.1016/S1474-4422(18)30336-3.
|
[2] |
SPOSATO LA, HILZ MJ, ASPBERG S, et al. Post-stroke cardiovascular complications and neurogenic cardiac injury: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2020, 76(23): 2768-2785. DOI: 10.1016/j.jacc.2020.10.009.
|
[3] |
BUCKLEY BJR, HARRISON SL, HILL A, et al. Stroke-heart syndrome: incidence and clinical outcomes of cardiac complications following stroke[J]. Stroke, 2022, 53(5): 1759-1763. DOI: 10.1161/STROKEAHA.121.037316.
|
[4] |
BALINT B, JAREMEK V, THORBURN V, et al. Left atrial microvascular endothelial dysfunction, myocardial inflammation and fibrosis after selective insular cortex ischemic stroke[J]. Int J Cardiol, 2019, 292: 148-155. DOI: 10.1016/j.ijcard.2019.06.004.
|
[5] |
MELOUX A, RIGAL E, ROCHETTE L, et al. Ischemic stroke increases heart vulnerability to ischemia-reperfusion and alters myocardial cardioprotective pathways[J]. Stroke, 2018, 49(11): 2752-2760. DOI: 10.1161/STROKEAHA.118.022207.
|
[6] |
ZHOU Y, ZHANG Y, CUI M, et al. Prognostic value of the systemic inflammation response index in patients with acute ischemic stroke[J]. Brain Behav, 2022, 12(6): e2619. DOI: 10.1002/brb3.2619.
|
[7] |
COURTIES G, FRODERMANN V, HONOLD L, et al. Glucocorticoids regulate bone marrow B lymphopoiesis after stroke[J]. Circ Res, 2019, 124(9): 1372-1385. DOI: 10.1161/CIRCRESAHA.118.314518.
|
[8] |
ZHANG X, LEI B, YUAN Y, et al. Brain control of humoral immune responses amenable to behavioural modulation[J]. Nature, 2020, 581(7807): 204-208. DOI: 10.1038/s41586-020-2235-7.
|
[9] |
DING Y, DEGRACIA D, GENG X, et al. Perspectives on effect of spleen in ischemic stroke[J]. Brain Circ, 2022, 8(3): 117-120. DOI: 10.4103/bc.bc_53_22.
|
[10] |
STEPHENS R, GRAINGER JR, SMITH CJ, et al. Systemic innate myeloid responses to acute ischaemic and haemorrhagic stroke[J]. Semin Immunopathol, 2022, DOI: 10.1007/s00281-022-00968-y[Epub ahead of print].
|
[11] |
CANDELARIO-JALIL E, DIJKHUIZEN RM, MAGNUS T. Neuroinflammation, stroke, blood-brain barrier dysfunction, and imaging modalities[J]. Stroke, 2022, 53(5): 1473-1486. DOI: 10.1161/STROKEAHA.122.036946.
|
[12] |
VORNHOLZ L, NIENHAUS F, GLIEM M, et al. Acute heart failure after reperfused ischemic stroke: association with systemic and cardiac inflammatory responses[J]. Front Physiol, 2021, 12: 782760. DOI: 10.3389/fphys.2021.782760.
|
[13] |
YAN T, CHEN Z, CHOPP M, et al. Inflammatory responses mediate brain-heart interaction after ischemic stroke in adult mice[J]. J Cereb Blood Flow Metab, 2020, 40(6): 1213-1229. DOI: 10.1177/0271678X18813317.
|
[14] |
DU Y, DEMILLARD LJ, REN J. Catecholamine-induced cardiotoxicity: a critical element in the pathophysiology of stroke-induced heart injury[J]. Life Sci, 2021, 287: 120106. DOI: 10.1016/j.lfs.2021.120106.
|
[15] |
SHI K, TIAN DC, LI ZG, et al. Global brain inflammation in stroke[J]. Lancet Neurol, 2019, 18(11): 1058-1066. DOI: 10.1016/S1474-4422(19)30078-X.
|
[16] |
MO Y, SUN YY, LIU KY. Autophagy and inflammation in ischemic stroke[J]. Neural Regen Res, 2020, 15(8): 1388-1396. DOI: 10.4103/1673-5374.274331.
|
[17] |
ISHIKAWA H, TAJIRI N, VASCONCELLOS J, et al. Ischemic stroke brain sends indirect cell death signals to the heart[J]. Stroke, 2013, 44(11): 3175-3182. DOI: 10.1161/STROKEAHA.113.001714.
|
[18] |
AKSU T, GOPINATHANNAIR R, GUPTA D, et al. Intrinsic cardiac autonomic nervous system: what do clinical electrophysiologists need to know about the "heart brain"?[J]. J Cardiovasc Electrophysiol, 2021, 32(6): 1737-1747. DOI: 10.1111/jce.15058.
|
[19] |
BIEBER M, WERNER RA, TANAI E, et al. Stroke-induced chronic systolic dysfunction driven by sympathetic overactivity[J]. Ann Neurol, 2017, 82(5): 729-743. DOI: 10.1002/ana.25073.
|
[20] |
SCHWARZ K, AHEARN T, SRINIVASAN J, et al. Alterations in cardiac deformation, timing of contraction and relaxation, and early myocardial fibrosis accompany the apparent recovery of acute stress-induced (Takotsubo) cardiomyopathy: an end to the concept of transience[J]. J Am Soc Echocardiogr, 2017, 30(8): 745-755. DOI: 10.1016/j.echo.2017.03.016.
|
[21] |
YANG D, DAI X, XING Y, et al. Intrinsic cardiac adrenergic cells contribute to LPS-induced myocardial dysfunction[J]. Commun Biol, 2022, 5(1): 96. DOI: 10.1038/s42003-022-03007-6.
|
[22] |
CEREUIL A, RONFLÉ R, CULVER A, et al. Septic shock: phenotypes and outcomes[J]. Adv Ther, 2022, 39(11): 5058-5071. DOI: 10.1007/s12325-022-02280-5.
|
[23] |
SPOSATO LA, LAM M, ALLEN B, et al. First-ever ischemic stroke and increased risk of incident heart disease in older adults[J]. Neurology, 2020, 94(15): e1559-e1570. DOI: 10.1212/WNL.0000000000009234.
|
[24] |
PUTAALA J, LEHTO M, MERETOJA A, et al. In-hospital cardiac complications after intracerebral hemorrhage[J]. Int J Stroke, 2014, 9(6): 741-746. DOI: 10.1111/ijs.12180.
|
[25] |
AHMADIAN A, MIZZI A, BANASIAK M, et al. Cardiac manifestations of subarachnoid hemorrhage[J]. Heart Lung Vessel, 2013, 5(3): 168-178.
|
[26] |
DOSHI R, NEIL-DWYER G. A clinicopathological study of patients following a subarachnoid hemorrhage[J]. J Neurosurg, 1980, 52(3): 295-301. DOI: 10.3171/jns.1980.52.3.0295.
|
[27] |
LETTOW I, JENSEN M, SCHLEMM E, et al. Serious adverse events and their impact on functional outcome in acute ischemic stroke in the WAKE-UP trial[J]. Stroke, 2021, 52(12): 3768-3776. DOI: 10.1161/STROKEAHA.120.033425.
|
[28] |
SCHEITZ JF, SPOSATO LA, SCHULZ-MENGER J, et al. Stroke-heart syndrome: recent advances and challenges[J]. J Am Heart Assoc, 2022, 11(17): e026528. DOI: 10.1161/JAHA.122.026528.
|
[29] |
STENGL H, GANESHAN R, HELLWIG S, et al. Cardiomyocyte injury following acute ischemic stroke: protocol for a prospective observational cohort study[J]. JMIR Res Protoc, 2021, 10(2): e24186. DOI: 10.2196/24186.
|
[30] |
SIMATS A, LIESZ A. Systemic inflammation after stroke: implications for post-stroke comorbidities[J]. EMBO Mol Med, 2022, 14(9): e16269. DOI: 10.15252/emmm.202216269.
|
[31] |
VENKAT P, CUI C, CHEN Z, et al. CD133+exosome treatment improves cardiac function after stroke in type 2 diabetic mice[J]. Transl Stroke Res, 2021, 12(1): 112-124. DOI: 10.1007/s12975-020-00807-y.
|
[32] |
SIEDLER G, SOMMER K, MACHA K, et al. Heart failure in ischemic stroke: relevance for acute care and outcome[J]. Stroke, 2019, 50(11): 3051-3056. DOI: 10.1161/STROKEAHA.119.026139.
|
[33] |
JAPUNDŽIĆ-ŽIGON N, ŠARENAC O, LOZIĆ M, et al. Sudden death: neurogenic causes, prediction and prevention[J]. Eur J Prev Cardiol, 2018, 25(1): 29-39. DOI: 10.1177/2047487317736827.
|
[34] |
KIM AS, MOFFATT E, URSELL PC, et al. Sudden neurologic death masquerading as out-of-hospital sudden cardiac death[J]. Neurology, 2016, 87(16): 1669-1673. DOI: 10.1212/WNL.0000000000003238.
|
[35] |
HINTERDOBLER J, SCHOTT S, JIN H, et al. Acute mental stress drives vascular inflammation and promotes plaque destabilization in mouse atherosclerosis[J]. Eur Heart J, 2021, 42(39): 4077-4088. DOI: 10.1093/eurheartj/ehab371.
|
[36] |
BILGE S, TEZEL O, ACAR YA, et al. Investigation of the value of T peak to T end and QTc intervals as electrocardiographic arrhythmia susceptibility markers in acute ischemic stroke[J]. Noro Psikiyatr Ars, 2020, 57(3): 171-176. DOI: 10.29399/npa.24996.
|
[37] |
DANIELE O, CARAVAGLIOS G, FIERRO B, et al. Stroke and cardiac arrhythmias[J]. J Stroke Cerebrovasc Dis, 2002, 11(1): 28-33. DOI: 10.1053/jscd.2002.123972.
|
[38] |
WILHELM MJ, PRATSCHKE J, BEATO F, et al. Activation of the heart by donor brain death accelerates acute rejection after transplantation[J]. Circulation, 2000, 102(19): 2426-2433. DOI: 10.1161/01.cir.102.19.2426.
|
[39] |
KHUSH KK, POTENA L, CHERIKH WS, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult heart transplantation report-2020; focus on deceased donor characteristics[J]. J Heart Lung Transplant, 2020, 39(10): 1003-1015. DOI: 10.1016/j.healun.2020.07.010.
|
[40] |
OEHLER D, IMMOHR MB, ERBEL-KHURTSIDZE S, et al. Intracerebral bleeding in donors is associated with reduced short-term to midterm survival of heart transplant recipients[J]. ESC Heart Fail, 2022, 9(4): 2419-2427. DOI: 10.1002/ehf2.13935.
|
[41] |
MIKAMI T, ITAGAKI S, FUJISAKI T, et al. Association of donor brain death due to stroke with prognosis after heart transplantation[J]. J Am Coll Cardiol, 2022, 79(11): 1063-1072. DOI: 10.1016/j.jacc.2021.12.031.
|
[42] |
KRISHNAMURTHI RV, FEIGIN VL, FOROUZANFAR MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010[J]. Lancet Glob Health, 2013, 1(5): e259-e281. DOI: 10.1016/S2214-109X(13)70089-5.
|
[43] |
JO YJ, KIM DH, SOHN MK, et al. Clinical characteristics and risk factors of first-ever stroke in young adults: a multicenter, prospective cohort study[J]. J Pers Med, 2022, 12(9): 1505. DOI: 10.3390/jpm12091505.
|
[44] |
CHO BH, KIM JH, SUH SH, et al. Characteristics of intracranial aneurysms according to levels of coronary artery calcium[J]. Stroke, 2019, 50(6): 1403-1408. DOI: 10.1161/STROKEAHA.119.024726.
|
[45] |
RIVINIUS R, HELMSCHROTT M, RUHPARWAR A, et al. Elevated pre-transplant pulmonary vascular resistance is associated with early post-transplant atrial fibrillation and mortality[J]. ESC Heart Fail, 2020, 7(1): 176-187. DOI: 10.1002/ehf2.12549.
|
[46] |
VAN TRIGT P, BITTNER HB, KENDALL SW, et al. Mechanisms of transplant right ventricular dysfunction[J]. Ann Surg, 1995, 221(6): 666-675. DOI: 10.1097/00000658-199506000-00006.
|
[47] |
SZABÓ G, SEBENING C, HAGL C, et al. Right ventricular function after brain death: response to an increased afterload[J]. Eur J Cardiothorac Surg, 1998, 13(4): 449-458. DOI: 10.1016/s1010-7940(98)00049-9.
|